Skip to main content

and
  1. Article

    Open Access

    Prognostic factors and clinical efficacy of second-line treatments of Pneumocystis jirovecii pneumonia for non-HIV patients after first-line treatment failure

    Pneumocystis jirovecii pneumonia (PCP) is a life-threatening opportunistic infection. In non-HIV immunocompromised patients with PCP, a standard second-line treatment has not been established up to now.

    Anlei Liu, Ruixue Sun, Guanghui Cao, **aohang Liu, Huadong Zhu in BMC Infectious Diseases (2022)

  2. Article

    Open Access

    Klebsiella pneumoniae pneumonia in patients with rheumatic autoimmune diseases: clinical characteristics, antimicrobial resistance and factors associated with extended-spectrum β-lactamase production

    Over the past decades, Klebsiella pneumoniae (K. pneumoniae) infections have been increasing and affected immunocompromised patients nosocomially and communally, with extended-spectrum β-lactamase (ESBL) producti...

    Yang Liu, Yecheng Liu, Jiayuan Dai, Anlei Liu, Yi Li, Jun Xu in BMC Infectious Diseases (2021)

  3. Article

    Open Access

    Klebsiella pneumoniae-related invasive liver abscess syndrome complicated by purulent meningitis: a review of the literature and description of three cases

    Klebsiella pneumoniae (K. pneumoniae) invasive liver abscess syndrome (ILAS) with purulent meningitis was rarely identified the mainland of China. Last winter, we received 3 cases of K. pneumoniae meningitis and ...

    Ruixue Sun, Hui Zhang, Yingchun Xu, Huadong Zhu, Xuezhong Yu in BMC Infectious Diseases (2021)